Ortoma announces agreement to provide AI-based solution for total hip arthroplasty

Published September 20, 2023

Ortoma AB, a Swedish medical technology company, has announced that it has signed a development and distribution agreement with DePuy Ireland Unlimited Company (“DePuy Synthes”), part of Johnson & Johnson MedTech. The deal will allow Ortoma to integrate DePuy Synthes’ technology into its customized Ortoma Treatment Solution (OTS) for hip replacement surgery.

Linus Byström, CEO of Ortoma, stated, “Ortoma is moving step by step towards global establishment of OTS and through our strategic collaboration we will be able to reach important markets such as the US and Europe.”

The market launch of Custom OTS is expected to take place in 2024 with an initial focus on sales in the markets where regulatory clearances have been obtained.

Ortoma Treatment Solution (OTS™) is a product used for orthopedic procedures, specifically for hip surgery, that includes OTS™ Hip Plan and OTS™ Hip Guide for preoperative planning, intraoperative navigation, and postoperative follow-up of hip implant surgery. The system’s software, which is based on artificial intelligence, enables improved accuracy, efficiency, and surgical results.

About Ortoma AB (publ)
Ortoma AB develops surgical systems for the planning and positioning of implants in hip, knee and spinal surgery. The purpose of the company’s surgical system, Ortoma Treatment Solution™ (OTS) is to enable surgeons to accurately measure and plan 3D surgery for the placement of joint implants, and during surgery, to optimally position the implant in the patient. Ortoma’s surgical system is aimed at providing better patient outcomes, fewer complications and less follow-up surgeries – and thus better long-term survival rates for implants. OTS is a system that is easily integrated into the processes and routines currently used in surgery, thereby increasing efficiency. Globally, more than 7.5 million orthopedic procedures are performed each year where OTS could be used in hip, knee and spinal surgery. In Sweden, around 42,000 surgical procedures were performed last year, involving hip, knee or spinal surgery. Ortoma’s B shares are listed on Nasdaq First North Growth Market Stockholm.